CYP1A1 gene polymorphisms as a risk factor for pterygium

Molecular Vision

Volumn 16, Issue , 2010, Pages 1054-1058

  Young, Chi Hsien ^a,b   Lo, Yu Lun ^c,d   Tsai, Yi Yu ^e   Shih, Tung Sheng ^b,c   Lee, Huei ^a   Cheng, Ya Wen ^a,f  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b Institute of Occupational Safety and Health   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE M1;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; DISEASE COURSE; DNA EXTRACTION; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MALE; METABOLITE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PTERYGIUM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; WILD TYPE;

AGED; AGED, 80 AND OVER; CYTOCHROME P-450 CYP1A1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PTERYGIUM;

EID: 77955643789     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Lee H, Su SY, Liu KS, Chou MC. Correlation between meteorological conditions and mutagenicity of airborne particulate samples in a tropical monsoon climate area from Kaohsiung city, Taiwan. Environ Mol Mutagen 1994; 23:200-7.
2. Kuo CY, Cheng YW, Chen CY, Lee H. Correlation between the amounts of polycyclic aromatic hydrocarbons and mutagenicity of airborne particulate samples from Taichung city, Taiwan. Environ Res 1998; 78:43-9.
3. Hussain SP, Amstad P, Raja K, Sawyer M, Hofseth L, Shields PG, Hewer A, Phillips DH, Ryberg D, Haugen A, Harris CC. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung. Cancer Res 2001; 61:6350-5.
4. Tsai YY, Cheng YW, Lee H, Tsai FJ, Tseng SH, Chang KC. P53 gene mutation spectrum and the relationship between gene mutation and protein expression in pterygium. Mol Vis 2005; 11:50-5.
5. Shimada T, Yun CH, Yamasaki H, Gautier C, Beaune PH, Guengerich P. Characterization of human lung microsomal cytochrome P450 1A1 and its role in the oxidation of chemical carcinogens. Mol Pharmacol 1992; 41:856-64.
6. London SJ, Daly AK, Leathart JBS, Navidi WC, Idle JR. Lung cancer risk in relation to the CYP2C9*1/CYP2CP*2 genetic polymorphism among Africa-Americans and Caucasians in Los Angeles County, California. Pharmacogenetics 1996; 6:527-33.
7. Bartsch H, Nair U, Risch A, Rojas M, Wilkman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000; 9:3-28.
8. Kawajiri K, Nakachi K, Imai K, Yoshii A, Shinoda N, Watanabe J. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS Lett 1990; 263:131-3.
9. Hayashi S, Watanabe J, Kawajiri K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and Mu-class glutathione S-transferase genes. Jpn J Cancer Res 1992; 83:866-70.
10. Kao SY, Wu CH, Lin SC, Yap SK, Chang CS, Wong YK, Chi LY, Liu TY. Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precancer lesions associated with smoking/betel use. J Oral Pathol Med 2002; 31:505-11.
11. Ketterer B, Harris JM, Talaska G, Meyer DJ, Pemble SE, Taylor JB, Lang NP, Kadlubar FF. The human glutathioneStransferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect 1992; 98:87-94.
12. Sundberg K, Seidel A, Mannervik B, Jernstrom B. Detoxification of carcinogenic fjord-region diol epoxides of polycyclic aromatic hydrocarbons by glutathione transferase P1-1 variants and glutathione. FEBS Lett 1998; 438:206-10.
13. Coles B, Ketterer B. The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol 1990; 25:47-70.
14. Seidegard J, Pero RW, Markowitz MM, Roush G, Miller DG, Beattie EJ. Isoenzyme(s) of glutathione transferase (class A) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis 1990; 11:33-6.
15. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB. Human glutathione Stransferase (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 15:271-6.
16. McWilliams JE, Sanderson BJ, Harris EL, Richert-Boe KE, Henner WD. Glutathione S-transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev 1995; 4:589-94.
17. Sato M, Sato T, Izumo T, Amagasa T. Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 1999; 20:1927-31.
18. Katoh T, Kaneko S, Kohshi K, Munaka M, Kitagawa K, Kunugita N, Kunugita N, Ikemura K, Kawamoto T. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer 1999; 83:606-9.
19. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993; 85:1159-64.
20. Tung JN, Wu HH, Chiang CC, Tsai YY, Chou MC, Lee H, Cheng YW. An association between BPDE-like DNA adduct levels and CYP1A1 and GSTM1 polymorphisma in pterygium. Mol Vis 2010; 16:623-9.
21. Gaillard C, Strauss F. Ethanol precipitation of DNA with linear polyacrylamide as carrier. Nucleic Acids Res 1990; 18:378.
22. Hayashi S, Watanabe J, Nakachi K, Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J Biochem 1991; 110:407-11.
23. Groppi A, Couttele C, Fleury B, Iron A, Beugeret J, Couzigous P. Glutathione S-transferase class mu in French alcoholic cirrhotic patients. Hum Genet 1991; 87:628-30.
24. Lai TJ, Tsai YY, Cheng YW, Chiang CC, Lee H, Chou MC, Chang JH. An association between BPDE-like DNA adducts levels and P53 gene mutation in pterygium. Mol Vis 2006; 12:1687-91.
25. Kerb R, Brockmoller J, Reum T, Roots I. Deficiency of glutathione S-transferases T1 and M1 as heritable factors of increased cutaneous UV sensitivity. J Invest Dermatol 1997; 108:229-32.
26. Halliwell B, Gutteridge JMC. Antioxidant defences. In: Halliwell B, Gutteridge JMC, editors. Free Radicals in Biology and Medicine. 3rd ed. Oxford: Clarendon Press; 1999. p. 105-245.
27. Strange RC, Lear JT, Fryer AA. Polymorphism in glutathione Stransferase loci as a risk factor for common cancers. Arch Toxicol Suppl 1998; 20:419-28.
28. Ollier W, Davies E, Snowden N, Alldersea J, Fryer A, Jones P, Strange R. Association of homozygosity for glutathione-Stransferase GSTM1 null alleles with the Ro+/Laautoantibody profile in patients with systemic lupus erythematosus. Arthritis Rheum 1996; 39:1763-4.
29. Tsai YY, Lee H, Tseng SH, Cheng YW, Tsai CH, Wu YH, Tsai FJ. Null type of glutathione S-transferase M1 polymorphism is associated with early onset pterygium. Mol Vis 2004; 10:458-61.
30. Hainaut P, Vähäkangas K. p53 as a sensor of carcinogenic exposures: mechanisms of p53 protein induction and lessons from p53 gene mutations. Pathol Biol (Paris) 1997; 45:833-44.
31. Wei M, Wanibuchi H, Morimura K, Iwai S, Yoshida K, Endo G, Nakae D, Fukushima S. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis 2002; 23:1387-97.
32. Hollstein M, Sidransky D, Vogelstein B. at al. p53 mutations in human cancers. Science 1991; 253:49-53.
33. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54:4855-78.
34. Hussain SP, Harris CC. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 1998; 58:4023-37.